Weight-loss drugs are changing travel, and the industry is only beginning to adjust

The rise of GLP-1 weight-loss medications is starting to reshape the travel business in ways that go far beyond health and wellness. What began as a pharmaceutical shift is now influencing how people eat, drink, shop, exercise and choose experiences while on vacation. According to a March 16, 2026, Travel Weekly report, travel advisors, wellness operators and cruise specialists are already seeing measurable changes in traveler behavior, from reduced interest in long lunches and wine-focused outings to stronger demand for active excursions, private shopping and medically grounded wellness support.

That matters because travel has long been built around indulgence. Restaurants, bars, buffets, cocktail culture and food-driven itineraries have been central to how destinations market themselves and how advisors build trips. Travel Weekly reports that Embark Beyond founder Jack Ezon has seen clients increasingly skip lunch, show less interest in heavy dining experiences and move away from alcohol-centered plans. He also pointed to rising demand for private shopping, particularly in fashion capitals, as clients update wardrobes after major weight loss.

The broader economic backdrop suggests this is not a niche trend. Travel Weekly cites a JAMA Network Open study showing U.S. spending on GLP-1 medications rose from $13.7 billion in 2018 to $71.7 billion in 2023, while a PwC study found that about 20% of U.S. households included at least one GLP-1 user in 2025, up from roughly 9% the year before. If that rate of adoption continues, the travel sector is not dealing with a temporary consumer fad, but with a structural shift in how a growing share of travelers approaches leisure, food, wellness and spending.

One of the clearest changes is that the value proposition of travel may be moving away from quantity and toward selectivity. PwC consumer markets leader Ali Furman said overall dessert consumption among GLP-1 users drops sharply, but premium dessert purchasing rises. That suggests travelers using these medications may still spend, but more deliberately. Instead of building vacations around multiple large meals, bottomless drinks or all-you-can-eat formats, they may place more value on fewer, higher-quality dining moments and on experiences that feel more curated. For hotels and destinations, this is not necessarily bad news, but it does mean old assumptions about what people want from a vacation may no longer hold.

That may be especially significant for cruise lines and all-inclusive resorts, sectors that historically leaned heavily on abundance as a selling point. Travel Weekly found that major cruise companies either declined to comment or did not respond when asked how they were adapting, but advisors interviewed for the article said the effects are likely to extend from food service to excursion planning. Luxury travel advisor Nick Pena said clients who once would have preferred cruises or all-inclusive stays are now considering island vacations and other formats where the focus is less on constant eating and more on destination experience. He also suggested that premium and luxury cruises are currently better positioned because they already emphasize quality over volume in food service.

That insight may prove important. If GLP-1 adoption keeps expanding, the strongest travel brands may be the ones that shift fastest from excess to intention. Travelers who are eating less are not necessarily spending less overall. They may simply be reallocating spending, away from buffets and drink packages, and toward private tours, fitness offerings, shopping, cultural immersion and more comfortable room amenities. In that sense, the change is less about declining demand than changing demand. The winners may be businesses that recognize this early and redesign their products around how people now want to feel when they travel, not just what they want to consume. This is an inference drawn from the behavioral patterns described in the Travel Weekly report.

The wellness sector is already much farther along in that adjustment. Travel Weekly reports that the Pritikin Longevity Center initially felt a drag on bookings as some returning guests chose GLP-1 injections instead of wellness retreats. But that effect later stabilized as public understanding improved and more people came to see medication and lifestyle change as complementary rather than competing paths. Pritikin responded by tailoring programming for GLP-1 users, including more protein support, medical supervision and guidance for travelers dealing with side effects, muscle loss concerns or the transition off medication.

That shift points to a larger lesson for travel businesses. GLP-1 use is not just changing aesthetics, it is changing practical needs. Some injectable medications require refrigeration. Some users deal with gastrointestinal side effects. Others are being advised to focus more on strength training and muscle preservation than on weight loss itself. Travel Weekly reports that Furman sees growing interest among GLP-1 users in strength training and Pilates over cardio, while Pritikin’s William Donovan stressed the importance of medically based support for travelers using these therapies. For hotels, spas and retreats, that means “wellness” can no longer be treated as a vague marketing term. It increasingly needs to mean something operational, credible and individualized.

There is also a social and psychological dimension that the industry may be underestimating. The article suggests that advisors are learning to read cues carefully and discuss support needs respectfully, rather than treating medication use as a blunt sales category. Ezon’s advice, as reported by Travel Weekly, is to open the conversation discreetly and indirectly, for example by asking whether the client needs a refrigerator in the room for snacks rather than explicitly referencing medication. That approach reflects a broader truth: GLP-1 use sits at the intersection of health, privacy, identity and lifestyle. Travel brands that respond clumsily could alienate customers, while those that respond with tact may deepen loyalty.

For destinations, the trend may bring opportunity. Travel Weekly cites cruise destination specialists who believe places on land could be “the absolute winners” if travelers become more interested in active exploration. Beth Hatt of the Aquila Center for Cruise Excellence pointed to rising interest in guided bike tours, cultural walks and hikes, while consultant Ioannis Bras said destinations should promote more self-guided walking tours to capture demand from increasingly active visitors. If more travelers are moving away from passive consumption and toward motion-based exploration, destinations with strong trails, historic districts, waterfront promenades and outdoor cultural experiences may benefit.

This has implications for Caribbean tourism in particular. Many islands have long sold themselves through beach leisure, rum culture, large resort dining and cruise shopping. None of that disappears, but the balance may shift. A destination that can combine scenic appeal with walkability, water sports, moderate adventure, healthier food options and flexible excursion design may become more attractive to a segment of travelers whose habits are being changed by GLP-1 therapies. That is a reasonable inference from the Travel Weekly reporting on shore excursions and active exploration trends.

The article also hints at a more subtle reordering of travel culture itself. Dining used to structure the day. Now, according to Ezon, some clients plan around experiences instead. Bars remain central design features in many hotels, yet alcohol use patterns are also changing for some GLP-1 users, whether because of altered taste, reduced interest or a broader shift toward nonalcoholic options. Travel Weekly notes the growing prevalence of mocktail menus and increased attention to high-protein offerings. For hotel operators, that may eventually affect everything from menu design and minibar strategy to restaurant layouts and the kinds of signature experiences they promote.

None of this means food is no longer important in travel. It means the era of assuming more is better may be ending for a sizable portion of the market. Food may remain central, but in a more edited way: better ingredients, smaller portions, more specialized nutrition, less pressure to overindulge. Similarly, wellness may remain central, but with more emphasis on strength, recovery, metabolic health and credible guidance. Travel businesses that continue to market mainly through excess could find themselves out of step with travelers whose preferences have shifted more than the industry realizes. This is an analytical conclusion based on the trends and interviews reported by Travel Weekly.

The larger significance of the Travel Weekly report is that it captures an industry at the early stage of adaptation. The change is visible, but not yet fully absorbed into mainstream product design. Cruise lines remain largely quiet. Advisors are improvising in real time. Wellness brands are adjusting faster because the connection is more direct. Hotels and destinations are somewhere in the middle, aware of the trend but still learning what it means in operational terms.

What seems increasingly clear is that GLP-1 medications are not just influencing traveler bodies, they are influencing traveler expectations. People may want less food but better food, less drinking but better options, more movement, more medical credibility in wellness settings, and more experiences that align with a broader health journey. If that continues, the travel industry’s response will need to be more than cosmetic. It will require a genuine rethink of how vacations are designed, sold and experienced.

‍